Sally Beauty (SBH) Financials

$8.70 -0.15 (-1.69%)

Closing price 03:59 PM Eastern

Extended Trading

$8.90 +0.21 (+2.36%)

As of 05:57 PM Eastern

Annual Income Statements for Sally Beauty

This table shows Sally Beauty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Net Income / (Loss) Attributable to Common Shareholders	153	185	184	240	113	272	258	215	223	235	246
Consolidated Net Income / (Loss)	153	185	184	240	113	272	258	215	223	235	246
Net Income / (Loss) Continuing Operations	153	185	184	240	113	272	258	215	223	235	246
Total Pre-Tax Income	206	252	244	325	160	362	328	346	354	378	391
Total Operating Income	283	325	338	418	259	458	427	479	498	495	507
Total Gross Profit	1,890	1,898	1,919	1,953	1,716	1,911	1,944	1,965	1,964	1,898	1,860
Total Revenue	3,717	3,728	3,816	3,875	3,514	3,876	3,933	3,938	3,953	3,834	3,753
Operating Revenue	3,717	3,728	3,816	3,875	3,514	3,876	3,933	3,938	3,953	3,834	3,753
Total Cost of Revenue	1,827	1,830	1,896	1,922	1,799	1,966	1,988	1,973	1,989	1,936	1,893
Operating Cost of Revenue	1,827	1,830	1,896	1,922	1,799	1,966	1,988	1,973	1,989	1,936	1,893
Total Operating Expenses	1,608	1,573	1,582	1,535	1,457	1,452	1,518	1,486	1,466	1,403	1,353
Selling, General & Admin Expense	1,608	1,556	1,554	1,530	1,443	1,453	1,484	1,464	1,466	1,313	1,274
Restructuring Charge	-0.08	17	28	4.61	14	-0.68	34	23	-	-	-
Total Other Income / (Expense), net	-76	-73	-94	-94	-99	-96	-98	-133	-144	-117	-116
Interest Expense	76	73	94	94	99	96	98	133	144	117	116
Income Tax Expense	53	67	61	85	47	91	70	131	131	143	145
Basic Earnings per Share	$1.48	$1.72	$1.69	$2.13	$0.99	$2.27	$2.09	$1.56	$1.51	$1.50	$1.54
Weighted Average Basic Shares Outstanding	103.94M	107.33M	108.67M	112.65M	113.88M	119.64M	123.19M	137.53M	147.18M	156.35M	159.93M
Diluted Earnings per Share	$1.43	$1.69	$1.66	$2.10	$0.99	$2.26	$2.08	$1.56	$1.50	$1.49	$1.51
Weighted Average Diluted Shares Outstanding	106.93M	109.34M	110.29M	114.21M	114.68M	120.28M	123.83M	138.18M	148.80M	158.23M	163.42M
Weighted Average Basic & Diluted Shares Outstanding	101.88M	106.28M	107.04M	113.05M	112.82M	116.33M	123.50M	137.90M	147.60M	156.70M	159.70M

This table shows Sally Beauty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	61	38	29	38	43	51	41	50	21	47
Consolidated Net Income / (Loss)	61	38	29	38	43	51	41	50	21	47
Net Income / (Loss) Continuing Operations	61	38	29	38	43	51	41	50	21	47
Total Pre-Tax Income	83	51	39	52	57	71	55	69	22	63
Total Operating Income	100	72	60	69	77	90	71	87	39	99
Total Gross Profit	477	481	463	467	467	475	468	489	463	490
Total Revenue	938	942	908	931	921	931	919	957	962	961
Operating Revenue	938	942	908	931	921	931	919	957	962	961
Total Cost of Revenue	461	461	445	464	455	456	450	468	499	471
Operating Cost of Revenue	461	461	445	464	455	456	450	468	499	471
Total Operating Expenses	377	409	403	398	390	385	397	402	424	391
Selling, General & Admin Expense	377	409	403	398	391	384	390	392	398	391
Restructuring Charge	0.00	0.38	0.06	-0.09	-0.87	0.40	7.27	10	26	0.04
Total Other Income / (Expense), net	-17	-21	-21	-17	-20	-19	-17	-18	-17	-36
Interest Expense	17	21	21	17	20	19	17	18	17	36
Income Tax Expense	22	13	9.81	13	15	21	14	18	0.43	17
Basic Earnings per Share	$0.60	$0.37	$0.28	$0.36	$0.40	$0.47	$0.38	$0.47	$0.21	$0.44
Weighted Average Basic Shares Outstanding	102.02M	103.19M	104.28M	105.95M	107.33M	107.56M	107.45M	107.14M	108.67M	106.94M
Diluted Earnings per Share	$0.58	$0.36	$0.27	$0.35	$0.40	$0.46	$0.37	$0.46	$0.21	$0.43
Weighted Average Diluted Shares Outstanding	104.97M	105.90M	107.08M	108.72M	109.34M	109.67M	109.71M	109.46M	110.29M	108.53M
Weighted Average Basic & Diluted Shares Outstanding	101.95M	102.64M	103.51M	-	106.28M	107.77M	107.55M	107.33M	107.04M	107.02M

This table details how cash moves in and out of Sally Beauty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Net Change in Cash & Equivalents	-15	52	-330	-113	443	-5.80	14	-23	-53	33	59
Net Cash From Operating Activities	247	249	157	382	427	320	373	343	354	301	316
Net Cash From Continuing Operating Activities	247	249	157	382	427	320	373	343	354	301	316
Net Income / (Loss) Continuing Operations	153	185	184	240	113	272	258	215	223	235	246
Consolidated Net Income / (Loss)	153	185	184	240	113	272	258	215	223	235	246
Depreciation Expense	110	102	100	102	107	108	109	112	100	89	80
Amortization Expense	2.44	2.69	3.35	4.21	4.12	3.79	3.83	3.26	3.26	3.79	3.76
Non-Cash Adjustments To Reconcile Net Income	21	22	51	16	12	2.59	12	47	46	-2.74	7.82
Changes in Operating Assets and Liabilities, net	-40	-62	-182	19	191	-65	-9.62	-34	-18	-25	-21
Net Cash From Investing Activities	-109	-100	-102	-76	-124	-96	-95	-90	-175	-113	-82
Net Cash From Continuing Investing Activities	-109	-100	-102	-76	-124	-96	-95	-90	-175	-113	-82
Purchase of Property, Plant & Equipment	-101	-91	-99	-74	-111	-108	-87	-90	-151	-107	-77
Acquisitions	-7.75	-9.03	-3.17	-2.35	-13	-3.42	-9.18	-	-26	-6.47	-5.20
Sale of Property, Plant & Equipment	0.00	0.00	0.00	0.24	0.05	15	0.37	0.04	2.53	0.18	0.26
Net Cash From Financing Activities	-154	-101	-374	-420	140	-229	-263	-277	-232	-152	-174
Net Cash From Continuing Financing Activities	-154	-101	-374	-420	140	-229	-263	-277	-232	-152	-174
Repayment of Debt	-1,635	-1,376	-770	-424	-889	-778	-560	-1,225	-951	-1.81	-238
Repurchase of Common Equity	-60	-15	-130	0.00	-61	-47	-167	-347	-209	-228	-333
Issuance of Debt	1,541	1,290	520	0.02	1,088	594	462	1,277	912	0.98	356
Issuance of Common Equity	1.76	1.89	8.11	-	-	-	-	-	-	-	-
Other Financing Activities, net	-1.77	-1.17	-1.18	3.57	2.79	2.16	1.35	17	16	76	41
Effect of Exchange Rate Changes	1.08	-	-11	0.94	-	-1.04	-	-	-0.56	-2.55	-1.02
Cash Interest Paid	87	72	82	89	83	95	90	142	139	113	108
Cash Income Taxes Paid	36	64	83	80	50	84	70	115	124	108	139

This table details how cash moves in and out of Sally Beauty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Change in Cash & Equivalents	-2.43	11	0.20	-2.00	49	13	-37	29	-31	-126
Net Cash From Operating Activities	33	111	48	51	117	53	25	55	107	52
Net Cash From Continuing Operating Activities	33	111	48	51	117	53	25	55	107	52
Net Income / (Loss) Continuing Operations	61	48	38	38	43	51	41	50	21	47
Consolidated Net Income / (Loss)	61	48	38	38	43	51	41	50	21	47
Depreciation Expense	26	26	29	28	27	25	25	25	27	25
Amortization Expense	0.56	0.57	0.60	0.64	0.70	0.69	0.66	0.65	0.65	0.84
Non-Cash Adjustments To Reconcile Net Income	-20	3.78	6.50	5.12	21	-11	4.03	7.32	27	15
Changes in Operating Assets and Liabilities, net	-34	32	-25	-21	25	-13	-46	-29	32	-35
Net Cash From Investing Activities	23	-45	-19	-31	-36	-22	-17	-25	-35	-23
Net Cash From Continuing Investing Activities	23	-45	-19	-31	-36	-22	-17	-25	-35	-23
Purchase of Property, Plant & Equipment	-20	-37	-19	-31	-27	-22	-17	-25	-32	-23
Acquisitions	-0.37	-7.53	-	-0.22	-9.03	-	-	0.00	-2.50	-0.35
Sale of Property, Plant & Equipment	44	-	-	0.00	-	-	-	-	-	-
Net Cash From Financing Activities	-58	-56	-29	-23	-33	-19	-43	-5.99	-100	-147
Net Cash From Continuing Financing Activities	-58	-56	-29	-23	-33	-19	-43	-5.99	-100	-147
Repayment of Debt	-155	-242	-308	-68	-238	-235	-669	-234	-337	-431
Repurchase of Common Equity	-9.95	-9.89	-10	-20	-15	-	-	0.00	-	-
Issuance of Debt	112	196	289	67	221	216	624	229	237	283
Issuance of Common Equity	0.08	0.11	0.04	0.22	0.08	0.08	1.66	0.06	0.06	0.25
Other Financing Activities, net	-5.26	-0.01	0.00	-1.74	-0.03	-	-0.02	-1.13	-0.00	-0.03
Other Net Changes in Cash	-1.35	-	-	-	0.67	-	-	4.56	-	-
Cash Interest Paid	7.65	30	8.25	27	8.49	28	8.43	27	6.41	38
Cash Income Taxes Paid	19	1.51	2.47	3.50	12	20	29	3.08	8.75	17

This table presents Sally Beauty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Total Assets	2,793	2,725	2,577	2,847	2,895	2,098	2,097	2,099	2,132	2,094	2,004
Total Current Assets	1,305	1,228	1,132	1,384	1,433	1,164	1,155	1,142	1,173	1,187	1,104
Cash & Equivalents	108	123	71	401	514	71	77	64	87	140	107
Accounts Receivable	92	76	72	67	56	105	90	92	84	91	99
Inventories, net	1,037	975	936	871	815	953	944	931	907	885	828
Other Current Assets	69	54	53	45	48	35	43	55	55	37	39
Plant, Property, & Equipment, net	270	298	298	307	315	320	308	314	320	271	238
Total Noncurrent Assets	1,218	1,199	1,147	1,156	1,147	615	634	643	640	636	662
Goodwill	538	533	526	541	540	531	536	538	533	524	536
Intangible Assets	60	55	50	56	58	62	73	80	93	99	115
Other Noncurrent Operating Assets	619	611	570	559	549	22	25	25	14	13	11
Total Liabilities & Shareholders' Equity	2,793	2,725	2,577	2,847	2,895	2,098	2,097	2,099	2,132	2,094	2,004
Total Liabilities	2,164	2,217	2,283	2,566	2,880	2,159	2,366	2,463	2,408	2,392	2,351
Total Current Liabilities	593	579	668	665	563	456	491	573	489	492	464
Short-Term Debt	4.13	4.17	69	0.19	0.18	0.00	5.50	96	0.72	0.76	0.97
Accounts Payable	269	259	276	292	236	279	303	308	271	276	259
Accrued Expenses	163	163	161	206	171	169	180	167	215	209	199
Current Deferred & Payable Income Tax Liabilities	20	2.36	4.74	11	2.92	8.34	2.14	2.23	1.99	6.31	4.33
Other Current Liabilities	136	150	158	156	153	0.00	-	-	-	-	-
Total Noncurrent Liabilities	1,572	1,637	1,615	1,902	2,316	1,703	1,875	1,890	1,920	1,900	1,888
Long-Term Debt	978	1,066	1,083	1,383	1,797	1,595	1,769	1,772	1,783	1,787	1,785
Capital Lease Obligations	480	455	425	404	-	-	-	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	92	93	85	86	92	80	76	98	115	86	75
Other Noncurrent Operating Liabilities	22	23	22	29	427	28	30	20	22	28	28
Total Equity & Noncontrolling Interests	629	509	294	281	15	-60	-269	-364	-276	-298	-347
Total Preferred & Common Equity	629	509	294	281	15	-60	-269	-364	-276	-298	-347
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	629	509	294	281	15	-60	-269	-364	-276	-298	-347
Common Stock	1.02	6.74	5.31	18	3.04	1.17	1.20	1.30	1.45	1.52	1.55
Retained Earnings	741	625	440	357	117	56	-180	-283	-178	-219	-320
Accumulated Other Comprehensive Income / (Loss)	-113	-123	-152	-95	-105	-117	-90	-82	-100	-78	-29

This table presents Sally Beauty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	12/31/2024	6/30/2024	3/31/2024	6/30/2023	3/31/2023	12/31/2022	6/30/2022
Total Assets	2,711	2,721	2,747	2,675	2,675	2,669	2,686
Total Current Assets	1,247	1,263	1,280	1,199	1,209	1,219	1,243
Cash & Equivalents	106	97	97	74	62	99	101
Accounts Receivable	85	91	88	78	76	75	67
Inventories, net	1,006	1,022	1,040	996	1,024	987	1,015
Other Current Assets	51	51	56	51	48	58	60
Plant, Property, & Equipment, net	262	268	273	281	283	289	290
Total Noncurrent Assets	1,202	1,191	1,193	1,195	1,183	1,161	1,153
Goodwill	531	534	534	535	534	533	533
Intangible Assets	58	53	54	50	51	51	50
Other Noncurrent Operating Assets	613	604	604	610	598	577	569
Total Liabilities & Shareholders' Equity	2,711	2,721	2,747	2,675	2,675	2,669	2,686
Total Liabilities	2,054	2,144	2,196	2,188	2,249	2,295	2,390
Total Current Liabilities	549	595	644	566	631	677	775
Short-Term Debt	4.08	49	66	20	38	65	167
Accounts Payable	221	235	290	244	265	296	279
Accrued Expenses	149	161	150	140	168	143	166
Current Deferred & Payable Income Tax Liabilities	22	13	0.37	6.35	4.95	17	2.99
Other Current Liabilities	152	137	138	155	154	156	159
Total Noncurrent Liabilities	1,506	1,549	1,552	1,622	1,619	1,618	1,615
Long-Term Debt	938	979	978	1,065	1,065	1,082	1,084
Capital Lease Obligations	457	457	458	451	445	427	421
Noncurrent Deferred & Payable Income Tax Liabilities	89	91	94	84	86	86	93
Other Noncurrent Operating Liabilities	22	21	22	22	22	23	17
Total Equity & Noncontrolling Interests	656	578	551	488	426	373	296
Total Preferred & Common Equity	656	578	551	488	426	373	296
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	656	578	551	488	426	373	296
Common Stock	1.02	1.03	1.04	18	15	9.40	3.41
Retained Earnings	793	698	667	582	531	491	419
Accumulated Other Comprehensive Income / (Loss)	-137	-122	-117	-113	-120	-127	-126

This table displays calculated financial ratios and metrics derived from Sally Beauty's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.30%	-2.29%	-1.53%	10.26%	-9.34%	-1.43%	-0.15%	-0.36%	3.08%	2.15%	3.62%
EBITDA Growth	-8.19%	-2.45%	-15.99%	41.98%	-35.14%	5.69%	-9.25%	-1.17%	2.16%	-0.32%	-0.96%
EBIT Growth	-13.01%	-3.74%	-19.31%	61.71%	-43.56%	7.47%	-10.87%	-3.95%	0.60%	-2.30%	-2.57%
NOPAT Growth	-11.69%	-6.24%	-17.80%	68.62%	-46.73%	2.59%	12.57%	-5.10%	1.98%	-3.62%	-3.06%
Net Income Growth	-16.89%	0.57%	-23.47%	111.80%	-58.31%	5.26%	19.98%	-3.53%	-5.17%	-4.43%	-5.80%
EPS Growth	-15.38%	1.81%	-20.95%	112.12%	-56.19%	8.65%	33.33%	4.00%	0.67%	-1.32%	2.03%
Operating Cash Flow Growth	-1.12%	59.30%	-59.02%	-10.55%	33.23%	-14.02%	8.56%	-3.06%	17.73%	-4.81%	1.78%
Free Cash Flow Firm Growth	9.20%	4.78%	303.71%	-117.09%	12.26%	-10.85%	24.73%	14.92%	-16.54%	-11.22%	30.21%
Invested Capital Growth	3.76%	6.18%	7.97%	28.37%	-11.24%	2.40%	-0.84%	1.36%	5.30%	1.30%	-0.58%
Revenue Q/Q Growth	0.00%	-1.09%	-0.72%	0.84%	-0.23%	0.00%	-0.21%	-0.05%	0.31%	0.52%	1.02%
EBITDA Q/Q Growth	0.00%	9.64%	-13.67%	-1.97%	0.70%	2.28%	-1.73%	0.38%	-1.10%	-0.44%	-0.05%
EBIT Q/Q Growth	0.00%	13.13%	-17.58%	-1.99%	1.40%	2.91%	-1.98%	0.20%	-1.66%	-1.37%	-0.39%
NOPAT Q/Q Growth	0.00%	9.87%	-15.70%	-2.70%	4.08%	3.90%	-0.20%	-0.46%	-1.60%	-1.93%	-0.59%
Net Income Q/Q Growth	0.00%	13.00%	-20.32%	-0.84%	1.05%	5.36%	8.16%	-7.29%	-1.57%	-2.31%	-1.23%
EPS Q/Q Growth	0.00%	12.67%	-19.02%	-1.41%	4.21%	6.10%	9.47%	-4.29%	-0.66%	-1.97%	0.67%
Operating Cash Flow Q/Q Growth	-2.32%	3.86%	-26.65%	3.14%	9.19%	8.78%	-7.38%	4.61%	3.33%	-8.69%	2.99%
Free Cash Flow Firm Q/Q Growth	0.00%	-5.57%	152.55%	-118.83%	6.93%	9.07%	-3.79%	12.05%	-16.36%	-16.06%	30.02%
Invested Capital Q/Q Growth	0.00%	-1.97%	-3.60%	24.82%	-2.62%	-1.32%	-0.47%	-1.36%	0.82%	-2.23%	-5.68%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.86%	50.92%	50.30%	50.41%	48.82%	49.29%	49.44%	49.89%	49.69%	49.50%	49.56%
EBITDA Margin	10.62%	11.54%	11.56%	13.54%	10.52%	14.70%	13.71%	15.09%	15.21%	15.35%	15.73%
Operating Margin	7.61%	8.72%	8.85%	10.80%	7.36%	11.83%	10.85%	12.15%	12.61%	12.92%	13.51%
EBIT Margin	7.61%	8.72%	8.85%	10.80%	7.36%	11.83%	10.85%	12.15%	12.61%	12.92%	13.51%
Profit (Net Income) Margin	4.13%	4.95%	4.81%	6.19%	3.22%	7.01%	6.56%	5.46%	5.64%	6.13%	6.55%
Tax Burden Percent	74.36%	73.24%	75.20%	73.82%	70.79%	75.00%	78.57%	62.22%	62.97%	62.11%	62.97%
Interest Burden Percent	72.98%	77.55%	72.30%	77.65%	61.82%	78.99%	76.99%	72.23%	71.05%	76.41%	77.06%
Effective Tax Rate	25.64%	26.76%	24.80%	26.18%	29.21%	25.00%	21.43%	37.79%	37.03%	37.89%	37.03%
Return on Invested Capital (ROIC)	10.80%	12.83%	14.65%	20.84%	13.27%	23.79%	23.37%	20.81%	22.65%	22.94%	23.89%
ROIC Less NNEP Spread (ROIC-NNEP)	6.68%	9.16%	9.78%	15.66%	8.28%	19.30%	18.96%	16.09%	17.22%	18.58%	19.48%
Return on Net Nonoperating Assets (RNNOA)	16.18%	33.18%	49.26%	141.13%	-517.93%	-188.97%	-105.00%	-88.04%	-100.33%	-95.85%	-99.52%
Return on Equity (ROE)	26.98%	46.01%	63.91%	161.97%	-504.66%	-165.18%	-81.64%	-67.23%	-77.68%	-72.91%	-75.63%
Cash Return on Invested Capital (CROIC)	7.11%	6.83%	6.98%	-4.01%	25.17%	21.42%	24.21%	19.46%	17.49%	21.65%	24.47%
Operating Return on Assets (OROA)	10.25%	12.26%	12.45%	14.57%	10.36%	21.85%	20.33%	22.62%	23.58%	24.17%	25.64%
Return on Assets (ROA)	5.56%	6.96%	6.77%	8.35%	4.54%	12.95%	12.30%	10.17%	10.55%	11.47%	12.44%
Return on Common Equity (ROCE)	26.98%	46.01%	63.91%	161.97%	-504.66%	-165.18%	-81.64%	-67.23%	-77.68%	-72.91%	-75.63%
Return on Equity Simple (ROE_SIMPLE)	24.41%	36.29%	62.51%	85.44%	733.31%	-450.28%	-96.09%	-59.15%	-80.73%	-78.94%	-70.88%
Net Operating Profit after Tax (NOPAT)	210	238	254	309	183	344	335	298	314	308	319
NOPAT Margin	5.66%	6.39%	6.65%	7.97%	5.21%	8.87%	8.52%	7.56%	7.94%	8.02%	8.50%
Net Nonoperating Expense Percent (NNEP)	4.12%	3.68%	4.86%	5.17%	4.99%	4.49%	4.41%	4.72%	5.43%	4.36%	4.41%
Cost of Revenue to Revenue	49.14%	49.08%	49.70%	49.59%	51.18%	50.71%	50.56%	50.11%	50.31%	50.50%	50.44%
SG&A Expenses to Revenue	43.25%	41.74%	40.73%	39.49%	41.06%	37.48%	37.74%	37.16%	37.08%	34.25%	33.93%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	43.25%	42.20%	41.45%	39.61%	41.45%	37.46%	38.60%	37.74%	37.08%	36.58%	36.05%
Earnings before Interest and Taxes (EBIT)	283	325	338	418	259	458	427	479	498	495	507
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	395	430	441	525	370	570	539	594	601	589	590
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.22	1.78	4.59	6.78	63.50	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	45.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.37	0.24	0.35	0.49	0.28	0.46	0.56	0.65	0.95	0.97	1.13
Price to Earnings (P/E)	9.08	4.89	7.35	7.94	8.66	6.61	8.56	11.96	16.87	15.89	17.26
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	11.01%	20.44%	13.61%	12.59%	11.55%	15.13%	11.68%	8.36%	5.93%	6.29%	5.79%
Enterprise Value to Invested Capital (EV/IC)	1.39	1.21	1.59	1.97	1.74	2.27	2.73	3.04	3.84	3.99	4.45
Enterprise Value to Revenue (EV/Rev)	0.74	0.62	0.75	0.85	0.64	0.86	0.99	1.11	1.38	1.40	1.58
Enterprise Value to EBITDA (EV/EBITDA)	6.96	5.36	6.47	6.27	6.12	5.82	7.24	7.37	9.08	9.15	10.04
Enterprise Value to EBIT (EV/EBIT)	9.72	7.09	8.45	7.86	8.75	7.24	9.16	9.14	10.95	10.87	11.69
Enterprise Value to NOPAT (EV/NOPAT)	13.07	9.68	11.24	10.65	12.36	9.65	11.65	14.70	17.40	17.50	18.56
Enterprise Value to Operating Cash Flow (EV/OCF)	11.14	9.25	18.24	8.62	5.30	10.36	10.48	12.75	15.41	17.90	18.76
Enterprise Value to Free Cash Flow (EV/FCFF)	19.84	18.18	23.59	0.00	6.51	10.72	11.25	15.72	22.53	18.54	18.12
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.33	3.00	5.37	6.36	116.37	-26.43	-6.61	-5.14	-6.46	-6.00	-5.15
Long-Term Debt to Equity	2.32	2.99	5.13	6.36	116.36	-26.43	-6.59	-4.87	-6.46	-6.00	-5.14
Financial Leverage	2.42	3.62	5.03	9.01	-62.52	-9.79	-5.54	-5.47	-5.83	-5.16	-5.11
Leverage Ratio	4.85	6.61	9.44	19.39	-111.27	-12.76	-6.64	-6.61	-7.36	-6.36	-6.08
Compound Leverage Factor	3.54	5.12	6.83	15.06	-68.79	-10.08	-5.11	-4.78	-5.23	-4.86	-4.68
Debt to Total Capital	69.93%	74.99%	84.30%	86.42%	99.15%	103.93%	117.84%	124.17%	118.32%	119.99%	124.12%
Short-Term Debt to Total Capital	0.20%	0.21%	3.67%	0.01%	0.01%	0.00%	0.37%	6.39%	0.05%	0.05%	0.07%
Long-Term Debt to Total Capital	69.74%	74.78%	80.63%	86.41%	99.14%	103.93%	117.47%	117.78%	118.27%	119.94%	124.05%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	30.07%	25.01%	15.70%	13.58%	0.85%	-3.93%	-17.84%	-24.17%	-18.32%	-19.99%	-24.12%
Debt to EBITDA	3.70	3.55	3.58	3.40	4.86	2.80	3.29	3.14	2.97	3.04	3.03
Net Debt to EBITDA	3.43	3.26	3.42	2.64	3.47	2.67	3.15	3.04	2.82	2.80	2.84
Long-Term Debt to EBITDA	3.69	3.54	3.42	3.40	4.86	2.80	3.28	2.98	2.97	3.04	3.02
Debt to NOPAT	6.95	6.41	6.21	5.78	9.81	4.64	5.29	6.27	5.69	5.81	5.59
Net Debt to NOPAT	6.44	5.89	5.93	4.49	7.00	4.43	5.06	6.06	5.41	5.36	5.26
Long-Term Debt to NOPAT	6.93	6.39	5.94	5.78	9.81	4.64	5.28	5.95	5.68	5.81	5.59
Altman Z-Score	2.73	2.61	2.72	2.77	2.13	3.51	3.37	3.39	3.83	3.80	3.95
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.20	2.12	1.70	2.08	2.54	2.55	2.35	1.99	2.40	2.41	2.38
Quick Ratio	0.34	0.34	0.21	0.70	1.01	0.39	0.34	0.27	0.35	0.47	0.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	138	127	121	-59	348	310	347	278	242	290	327
Operating Cash Flow to CapEx	243.69%	274.75%	157.68%	518.35%	385.26%	346.61%	432.63%	383.02%	238.16%	282.83%	412.73%
Free Cash Flow to Firm to Interest Expense	1.81	1.74	1.29	-0.64	3.52	3.21	3.54	2.10	1.68	2.48	2.81
Operating Cash Flow to Interest Expense	3.23	3.42	1.67	4.08	4.32	3.33	3.80	2.58	2.46	2.57	2.72
Operating Cash Flow Less CapEx to Interest Expense	1.90	2.17	0.61	3.30	3.20	2.37	2.92	1.91	1.42	1.66	2.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.35	1.41	1.41	1.35	1.41	1.85	1.87	1.86	1.87	1.87	1.90
Accounts Receivable Turnover	44.23	50.33	54.96	63.00	43.67	39.75	43.04	44.70	45.15	40.45	38.55
Inventory Turnover	1.82	1.91	2.10	2.28	2.04	2.07	2.12	2.15	2.22	2.26	2.31
Fixed Asset Turnover	13.10	12.52	12.61	12.45	11.07	12.35	12.64	12.44	13.39	15.07	16.05
Accounts Payable Turnover	6.92	6.85	6.69	7.28	6.99	6.76	6.51	6.82	7.27	7.23	7.11
Days Sales Outstanding (DSO)	8.25	7.25	6.64	5.79	8.36	9.18	8.48	8.17	8.08	9.02	9.47
Days Inventory Outstanding (DIO)	201.00	190.64	173.97	160.11	179.32	176.13	172.13	169.99	164.50	161.50	157.77
Days Payable Outstanding (DPO)	52.78	53.32	54.60	50.14	52.25	54.02	56.09	53.56	50.22	50.46	51.37
Cash Conversion Cycle (CCC)	156.47	144.58	126.01	115.76	135.43	131.29	124.53	124.60	122.36	120.07	115.87
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,983	1,911	1,800	1,667	1,298	1,463	1,428	1,441	1,421	1,350	1,332
Invested Capital Turnover	1.91	2.01	2.20	2.61	2.55	2.68	2.74	2.75	2.85	2.86	2.81
Increase / (Decrease) in Invested Capital	72	111	133	368	-164	34	-12	19	71	17	-7.75
Enterprise Value (EV)	2,747	2,305	2,854	3,291	2,264	3,318	3,906	4,376	5,458	5,383	5,926
Market Capitalization	1,393	903	1,348	1,905	981	1,795	2,209	2,572	3,761	3,735	4,247
Book Value per Share	$6.12	$4.72	$2.74	$2.48	$0.14	($0.50)	($2.24)	($2.77)	($1.89)	($1.89)	($2.24)
Tangible Book Value per Share	$0.30	($0.74)	($2.64)	($2.80)	($5.17)	($5.42)	($7.30)	($7.47)	($6.16)	($5.86)	($6.43)
Total Capital	2,091	2,034	1,870	2,068	1,813	1,534	1,506	1,504	1,508	1,490	1,439
Total Debt	1,462	1,525	1,576	1,787	1,797	1,595	1,774	1,868	1,784	1,788	1,786
Total Long-Term Debt	1,458	1,521	1,508	1,787	1,797	1,595	1,769	1,772	1,783	1,787	1,785
Net Debt	1,354	1,402	1,506	1,386	1,283	1,523	1,697	1,804	1,697	1,648	1,679
Capital Expenditures (CapEx)	101	91	99	74	111	92	86	90	149	106	77
Debt-free, Cash-free Net Working Capital (DFCFNWC)	609	530	463	318	356	636	592	602	598	556	535
Debt-free Net Working Capital (DFNWC)	717	653	533	719	870	707	669	666	685	696	642
Net Working Capital (NWC)	713	649	464	719	870	707	664	569	684	695	641
Net Nonoperating Expense (NNE)	57	53	70	69	70	72	77	83	91	73	73
Net Nonoperating Obligations (NNO)	1,354	1,402	1,506	1,386	1,283	1,523	1,697	1,804	1,697	1,648	1,679
Total Depreciation and Amortization (D&A)	112	105	103	106	111	111	113	116	103	93	83
Debt-free, Cash-free Net Working Capital to Revenue	16.38%	14.21%	12.12%	8.20%	10.12%	16.41%	15.06%	15.28%	15.14%	14.50%	14.25%
Debt-free Net Working Capital to Revenue	19.28%	17.51%	13.97%	18.55%	24.75%	18.25%	17.02%	16.90%	17.33%	18.16%	17.09%
Net Working Capital to Revenue	19.17%	17.40%	12.17%	18.55%	24.75%	18.25%	16.88%	14.46%	17.31%	18.14%	17.07%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.48	$1.72	$1.69	$2.13	$0.99	$2.27	$2.09	$1.56	$1.51	$1.50	$1.54
Adjusted Weighted Average Basic Shares Outstanding	103.94M	107.33M	108.67M	112.65M	113.88M	119.64M	123.19M	137.53M	147.18M	156.35M	159.93M
Adjusted Diluted Earnings per Share	$1.43	$1.69	$1.66	$2.10	$0.99	$2.26	$2.08	$1.56	$1.50	$1.49	$1.51
Adjusted Weighted Average Diluted Shares Outstanding	106.93M	109.34M	110.29M	114.21M	114.68M	120.28M	123.83M	138.18M	148.80M	158.23M	163.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	101.88M	106.28M	107.04M	113.05M	112.82M	116.33M	120.14M	128.43M	144.11M	151.86M	155.20M
Normalized Net Operating Profit after Tax (NOPAT)	210	251	275	312	193	343	362	312	314	308	319
Normalized NOPAT Margin	5.65%	6.72%	7.20%	8.06%	5.50%	8.86%	9.19%	7.92%	7.94%	8.02%	8.50%
Pre Tax Income Margin	5.55%	6.76%	6.40%	8.39%	4.55%	9.34%	8.35%	8.78%	8.96%	9.87%	10.41%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.70	4.45	3.61	4.47	2.62	4.76	4.35	3.60	3.45	4.24	4.36
NOPAT to Interest Expense	2.75	3.26	2.71	3.30	1.85	3.57	3.41	2.24	2.18	2.63	2.74
EBIT Less CapEx to Interest Expense	2.38	3.21	2.55	3.69	1.50	3.80	3.47	2.93	2.42	3.33	3.70
NOPAT Less CapEx to Interest Expense	1.43	2.02	1.65	2.52	0.73	2.61	2.54	1.57	1.14	1.72	2.09
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	39.37%	8.21%	71.00%	0.00%	54.18%	17.46%	64.60%	161.28%	93.78%	96.80%	135.49%

This table displays calculated financial ratios and metrics derived from Sally Beauty's official financial filings.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.71%	1.22%	-1.13%	-2.69%	-4.27%	-3.17%	0.80%	-2.37%	-2.81%	-5.96%
EBITDA Growth	29.26%	-13.21%	-38.67%	-13.06%	56.96%	-6.96%	-12.84%	-18.54%	-51.25%	-18.62%
EBIT Growth	45.13%	-20.37%	-16.57%	-20.17%	96.21%	-9.15%	-17.41%	-23.22%	-64.75%	-22.14%
NOPAT Growth	44.19%	-17.26%	-16.33%	-19.31%	49.01%	-12.29%	-12.30%	-24.34%	-53.85%	-21.77%
Net Income Growth	58.93%	-25.77%	-28.43%	-23.73%	99.54%	9.14%	-12.71%	-26.88%	-68.69%	-38.89%
EPS Growth	65.71%	-21.74%	-27.03%	-23.91%	90.48%	6.98%	-11.90%	-23.33%	-65.00%	-34.85%
Operating Cash Flow Growth	-34.42%	-9.84%	0.00%	-7.15%	8.64%	2.16%	748.11%	1,066.60%	-34.64%	-39.66%
Free Cash Flow Firm Growth	-198.74%	300.12%	104.06%	552.08%	42.83%	96.01%	94.17%	-635.61%	66.86%	-601.28%
Invested Capital Growth	0.00%	0.84%	2.28%	0.00%	6.18%	4.41%	4.37%	35.44%	7.97%	39.80%
Revenue Q/Q Growth	0.00%	3.74%	0.00%	1.08%	-1.04%	1.34%	-4.01%	-0.56%	0.10%	5.49%
EBITDA Q/Q Growth	0.00%	69.35%	0.00%	-6.16%	-10.32%	19.67%	-13.68%	69.43%	-46.84%	12.10%
EBIT Q/Q Growth	0.00%	20.47%	0.00%	-10.12%	-14.67%	26.21%	-17.53%	120.91%	-60.49%	14.74%
NOPAT Q/Q Growth	0.00%	18.85%	0.00%	-10.55%	-10.65%	20.19%	-16.00%	65.19%	-47.41%	20.17%
Net Income Q/Q Growth	0.00%	29.00%	0.00%	-9.84%	-16.21%	24.38%	-18.83%	135.88%	-54.17%	-0.51%
EPS Q/Q Growth	0.00%	33.33%	0.00%	-12.50%	-13.04%	24.32%	-19.57%	119.05%	-51.16%	2.38%
Operating Cash Flow Q/Q Growth	-69.77%	0.00%	0.00%	-56.22%	119.38%	115.10%	-55.06%	-48.77%	106.29%	1,685.71%
Free Cash Flow Firm Q/Q Growth	0.00%	3,280.53%	0.00%	3,618.45%	-194.89%	31.43%	93.65%	-344.92%	79.39%	-0.03%
Invested Capital Q/Q Growth	0.00%	0.47%	0.00%	-100.00%	-1.97%	1.90%	3.46%	2.73%	-3.60%	1.86%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.84%	51.03%	50.98%	50.16%	50.64%	50.99%	50.98%	51.05%	48.16%	50.99%
EBITDA Margin	13.48%	10.71%	6.56%	10.50%	11.31%	12.49%	10.57%	11.76%	6.90%	12.99%
Operating Margin	10.70%	7.62%	6.56%	7.42%	8.35%	9.68%	7.77%	9.05%	4.07%	10.32%
EBIT Margin	10.70%	7.62%	6.56%	7.42%	8.35%	9.68%	7.77%	9.05%	4.07%	10.32%
Profit (Net Income) Margin	6.51%	4.00%	3.22%	4.12%	4.62%	5.46%	4.45%	5.26%	2.22%	4.84%
Tax Burden Percent	73.62%	73.88%	74.89%	74.10%	74.45%	71.11%	74.67%	73.31%	98.04%	73.65%
Interest Burden Percent	82.61%	71.15%	65.55%	74.95%	74.36%	79.30%	76.63%	79.30%	55.53%	63.73%
Effective Tax Rate	26.38%	26.12%	25.11%	25.90%	25.55%	28.89%	25.33%	26.69%	1.96%	26.35%
Return on Invested Capital (ROIC)	30.08%	0.00%	0.00%	0.00%	12.49%	13.60%	11.78%	15.65%	8.79%	18.24%
ROIC Less NNEP Spread (ROIC-NNEP)	28.09%	0.00%	0.00%	0.00%	11.48%	12.72%	10.96%	14.63%	7.61%	16.27%
Return on Net Nonoperating Assets (RNNOA)	55.34%	0.00%	0.00%	0.00%	41.60%	49.24%	47.86%	57.21%	38.31%	84.27%
Return on Equity (ROE)	85.42%	0.00%	0.00%	0.00%	54.09%	62.84%	59.64%	72.87%	47.10%	102.51%
Cash Return on Invested Capital (CROIC)	-176.12%	0.00%	0.00%	0.00%	6.83%	7.04%	7.81%	-15.58%	6.98%	-14.38%
Operating Return on Assets (OROA)	14.69%	0.00%	0.00%	0.00%	11.74%	13.61%	10.90%	12.42%	5.73%	14.52%
Return on Assets (ROA)	8.94%	0.00%	0.00%	0.00%	6.50%	7.68%	6.24%	7.22%	3.12%	6.81%
Return on Common Equity (ROCE)	85.42%	0.00%	0.00%	0.00%	54.09%	62.84%	59.64%	72.87%	47.10%	102.51%
Return on Equity Simple (ROE_SIMPLE)	26.81%	0.00%	0.00%	0.00%	0.00%	33.50%	37.36%	44.21%	0.00%	77.86%
Net Operating Profit after Tax (NOPAT)	74	53	45	51	57	64	53	63	38	73
NOPAT Margin	7.87%	5.63%	4.91%	5.50%	6.21%	6.88%	5.80%	6.63%	3.99%	7.60%
Net Nonoperating Expense Percent (NNEP)	1.99%	1.07%	1.06%	0.00%	1.01%	0.87%	0.82%	1.03%	1.18%	1.97%
Return On Investment Capital (ROIC_SIMPLE)	3.59%	-	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	49.16%	48.97%	49.02%	49.84%	49.36%	49.01%	49.02%	48.95%	51.84%	49.01%
SG&A Expenses to Revenue	40.15%	43.37%	44.41%	42.75%	42.39%	41.27%	42.41%	40.92%	41.34%	40.66%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	40.15%	43.41%	44.42%	42.74%	42.29%	41.31%	43.21%	42.00%	44.08%	40.67%
Earnings before Interest and Taxes (EBIT)	100	72	60	69	77	90	71	87	39	99
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	126	101	60	98	104	116	97	113	66	125
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.62	1.92	0.00	0.00	1.78	2.72	3.93	3.59	4.59	4.31
Price to Tangible Book Value (P/TBV)	15.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.29	0.00	0.00	0.39	0.24	0.35	0.44	0.35	0.35	0.33
Price to Earnings (P/E)	6.05	0.00	0.00	8.29	4.89	8.13	10.51	8.12	7.35	5.54
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	16.53%	0.00%	0.00%	12.06%	20.44%	12.30%	9.51%	12.32%	13.61%	18.06%
Enterprise Value to Invested Capital (EV/IC)	1.21	1.27	0.00	0.00	1.21	1.43	1.65	1.52	1.59	1.52
Enterprise Value to Revenue (EV/Rev)	0.63	0.00	0.00	0.00	0.62	0.74	0.83	0.74	0.75	0.74
Enterprise Value to EBITDA (EV/EBITDA)	5.57	0.00	0.00	0.00	5.36	7.11	7.88	6.78	6.47	5.57
Enterprise Value to EBIT (EV/EBIT)	7.51	0.00	0.00	0.00	7.09	9.71	10.66	9.04	8.45	6.95
Enterprise Value to NOPAT (EV/NOPAT)	10.13	0.00	0.00	0.00	9.68	12.88	13.96	12.06	11.24	9.45
Enterprise Value to Operating Cash Flow (EV/OCF)	10.30	9.90	0.00	0.00	9.25	11.62	13.22	12.97	18.24	13.34
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	18.18	20.78	21.60	0.00	23.59	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.13	2.57	2.73	0.00	3.00	3.15	3.64	4.22	5.37	5.65
Long-Term Debt to Equity	2.12	2.49	2.61	0.00	2.99	3.11	3.55	4.04	5.13	5.09
Financial Leverage	1.97	2.67	2.96	0.00	3.62	3.87	4.37	3.91	5.03	5.18
Leverage Ratio	4.13	5.07	5.55	0.00	6.61	6.84	7.77	8.44	9.44	10.55
Compound Leverage Factor	3.41	3.60	3.64	0.00	4.91	5.43	5.95	6.70	5.24	6.72
Debt to Total Capital	68.06%	72.00%	73.17%	0.00%	74.99%	75.90%	78.43%	80.84%	84.30%	84.97%
Short-Term Debt to Total Capital	0.20%	2.38%	3.22%	0.00%	0.21%	1.00%	1.93%	3.35%	3.67%	8.49%
Long-Term Debt to Total Capital	67.86%	69.61%	69.95%	0.00%	74.78%	74.90%	76.50%	77.49%	80.63%	76.47%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	31.94%	28.00%	26.83%	0.00%	25.01%	24.10%	21.57%	19.17%	15.70%	15.03%
Debt to EBITDA	3.30	0.00	0.00	0.00	3.55	3.91	3.86	3.79	3.58	3.27
Net Debt to EBITDA	3.05	0.00	0.00	0.00	3.26	3.73	3.71	3.55	3.42	3.08
Long-Term Debt to EBITDA	3.29	0.00	0.00	0.00	3.54	3.86	3.77	3.63	3.42	2.95
Debt to NOPAT	6.01	0.00	0.00	0.00	6.41	7.09	6.84	6.75	6.21	5.55
Net Debt to NOPAT	5.56	0.00	0.00	0.00	5.89	6.74	6.57	6.32	5.93	5.22
Long-Term Debt to NOPAT	5.99	0.00	0.00	0.00	6.39	6.99	6.67	6.47	5.94	5.00
Altman Z-Score	2.53	0.00	0.00	0.00	2.31	2.47	2.49	2.38	2.34	2.30
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.27	2.12	1.99	0.00	2.12	2.12	1.92	1.80	1.70	1.60
Quick Ratio	0.35	0.32	0.29	0.00	0.34	0.27	0.22	0.26	0.21	0.22
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1,876	37	1.08	1,900	-54	-18	-27	-420	-94	-458
Operating Cash Flow to CapEx	0.00%	250.12%	0.00%	167.00%	432.49%	245.77%	143.80%	219.74%	335.06%	224.86%
Free Cash Flow to Firm to Interest Expense	-107.55	1.77	0.05	109.74	-2.74	-0.98	-1.60	-23.45	-5.42	-12.74
Operating Cash Flow to Interest Expense	1.92	2.31	0.00	2.95	5.91	2.85	1.48	3.07	6.15	1.45
Operating Cash Flow Less CapEx to Interest Expense	3.27	1.39	0.00	1.18	4.54	1.69	0.45	1.67	4.32	0.80
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.37	0.00	0.00	0.00	1.41	1.41	1.40	1.37	1.41	1.41
Accounts Receivable Turnover	44.00	0.00	0.00	0.00	50.33	51.94	55.72	53.58	54.96	53.45
Inventory Turnover	1.81	0.00	0.00	0.00	1.91	1.86	1.90	1.89	2.10	1.94
Fixed Asset Turnover	14.23	0.00	0.00	0.00	12.52	13.20	13.30	13.02	12.61	13.42
Accounts Payable Turnover	8.26	0.00	0.00	0.00	6.85	7.16	7.47	5.87	6.69	6.88
Days Sales Outstanding (DSO)	8.30	0.00	0.00	0.00	7.25	7.03	6.55	6.81	6.64	6.83
Days Inventory Outstanding (DIO)	201.35	0.00	0.00	0.00	190.64	195.83	191.88	192.95	173.97	188.63
Days Payable Outstanding (DPO)	44.16	0.00	0.00	0.00	53.32	50.96	48.85	62.21	54.60	53.03
Cash Conversion Cycle (CCC)	165.48	0.00	0.00	0.00	144.58	151.90	149.58	137.56	126.01	142.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,950	1,965	1,956	0.00	1,911	1,949	1,913	1,849	1,800	1,867
Invested Capital Turnover	3.82	0.00	0.00	0.00	2.01	1.98	2.03	2.36	2.20	2.40
Increase / (Decrease) in Invested Capital	1,950	16	44	-1,849	111	82	80	484	133	531
Enterprise Value (EV)	2,358	2,499	0.00	0.00	2,305	2,790	3,159	2,816	2,854	2,846
Market Capitalization	1,065	1,111	0.00	1,431	903	1,328	1,672	1,340	1,348	1,275
Book Value per Share	$6.44	$5.58	$5.28	$0.00	$4.72	$4.53	$3.97	$3.49	$2.74	$2.77
Tangible Book Value per Share	$0.66	($0.09)	($0.36)	$0.00	($0.74)	($0.91)	($1.48)	($1.96)	($2.64)	($2.69)
Total Capital	2,055	2,063	2,053	0.00	2,034	2,023	1,974	1,948	1,870	1,968
Total Debt	1,399	1,485	1,503	0.00	1,525	1,536	1,548	1,575	1,576	1,672
Total Long-Term Debt	1,395	1,436	1,436	0.00	1,521	1,516	1,510	1,509	1,508	1,505
Net Debt	1,293	1,388	1,405	0.00	1,402	1,461	1,487	1,475	1,506	1,571
Capital Expenditures (CapEx)	-23	19	0.00	31	27	22	17	25	32	23
Debt-free, Cash-free Net Working Capital (DFCFNWC)	597	619	606	0.00	530	580	555	508	463	534
Debt-free Net Working Capital (DFNWC)	702	717	703	0.00	653	654	617	607	533	635
Net Working Capital (NWC)	698	668	637	0.00	649	634	578	542	464	468
Net Nonoperating Expense (NNE)	13	15	15	13	15	13	12	13	17	26
Net Nonoperating Obligations (NNO)	1,293	1,388	1,405	0.00	1,402	1,461	1,487	1,475	1,506	1,571
Total Depreciation and Amortization (D&A)	26	29	0.00	29	27	26	26	26	27	26
Debt-free, Cash-free Net Working Capital to Revenue	16.02%	0.00%	0.00%	0.00%	14.21%	15.38%	14.60%	13.40%	12.12%	13.89%
Debt-free Net Working Capital to Revenue	18.86%	0.00%	0.00%	0.00%	17.51%	17.35%	16.23%	16.01%	13.97%	16.53%
Net Working Capital to Revenue	18.75%	0.00%	0.00%	0.00%	17.40%	16.81%	15.22%	14.29%	12.17%	12.18%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.60	$0.37	$0.28	$0.00	$0.40	$0.47	$0.38	$0.47	$0.21	$0.44
Adjusted Weighted Average Basic Shares Outstanding	102.02M	103.19M	104.28M	0.00	107.33M	107.56M	107.45M	107.14M	108.67M	106.94M
Adjusted Diluted Earnings per Share	$0.58	$0.36	$0.27	$0.00	$0.40	$0.46	$0.37	$0.46	$0.21	$0.43
Adjusted Weighted Average Diluted Shares Outstanding	104.97M	105.90M	107.08M	0.00	109.34M	109.67M	109.71M	109.46M	110.29M	108.53M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	101.95M	102.64M	103.51M	0.00	106.28M	107.77M	107.55M	107.33M	107.04M	107.02M
Normalized Net Operating Profit after Tax (NOPAT)	74	53	45	51	57	64	59	71	64	73
Normalized NOPAT Margin	7.87%	5.66%	4.92%	5.49%	6.14%	6.91%	6.39%	7.43%	6.69%	7.60%
Pre Tax Income Margin	8.84%	5.42%	4.30%	5.56%	6.21%	7.68%	5.96%	7.17%	2.26%	6.58%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	5.75	3.47	2.90	3.99	3.90	4.83	4.28	4.83	2.25	2.76
NOPAT to Interest Expense	4.23	2.56	2.17	2.96	2.90	3.44	3.20	3.54	2.20	2.03
EBIT Less CapEx to Interest Expense	7.10	2.54	0.00	2.23	2.53	3.67	3.25	3.44	0.41	2.11
NOPAT Less CapEx to Interest Expense	5.58	1.64	0.00	1.19	1.54	2.28	2.17	2.15	0.37	1.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	28.48%	0.00%	0.00%	20.47%	8.21%	0.00%	0.00%	33.52%	71.00%	56.58%

Frequently Asked Questions About Sally Beauty's Financials

When does Sally Beauty's financial year end?

According to the most recent income statement we have on file, Sally Beauty's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Sally Beauty's net income changed over the last 10 years?

Sally Beauty's net income appears to be on a downward trend, with a most recent value of $153.41 million in 2024, falling from $245.99 million in 2014. The previous period was $184.60 million in 2023. Check out Sally Beauty's forecast to explore projected trends and price targets.

What is Sally Beauty's operating income?

Sally Beauty's total operating income in 2024 was $282.73 million, based on the following breakdown:

Total Gross Profit: $1.89 billion
Total Operating Expenses: $1.61 billion

How has Sally Beauty revenue changed over the last 10 years?

Over the last 10 years, Sally Beauty's total revenue changed from $3.75 billion in 2014 to $3.72 billion in 2024, a change of -1.0%.

How much debt does Sally Beauty have?

Sally Beauty's total liabilities were at $2.16 billion at the end of 2024, a 2.4% decrease from 2023, and a 8.0% decrease since 2014.

How much cash does Sally Beauty have?

In the past 10 years, Sally Beauty's cash and equivalents has ranged from $63.76 million in 2017 to $514.15 million in 2020, and is currently $107.96 million as of their latest financial filing in 2024.

How has Sally Beauty's book value per share changed over the last 10 years?

Over the last 10 years, Sally Beauty's book value per share changed from -2.24 in 2014 to 6.12 in 2024, a change of -373.8%.

Related Companies

This page (NYSE:SBH) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sally Beauty (SBH) Financials

Frequently Asked Questions About Sally Beauty's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sally Beauty (SBH) Financials

Annual Income Statements for Sally Beauty

Quarterly Income Statements for Sally Beauty

Annual Cash Flow Statements for Sally Beauty

Quarterly Cash Flow Statements for Sally Beauty

Annual Balance Sheets for Sally Beauty

Quarterly Balance Sheets for Sally Beauty

Annual Metrics And Ratios for Sally Beauty

Quarterly Metrics And Ratios for Sally Beauty

Frequently Asked Questions About Sally Beauty's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools